Perspective Therapeutics (CATX) EBT Margin (2010 - 2023)

Perspective Therapeutics has disclosed EBT Margin across 14 years of filings, most recently posting 158.57% for Q4 2023.

• EBT Margin for Q4 2023 came in at 158.57%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was 6542.58% (changed N/A YoY), and the FY2023 annual result was 2796.79%, changed N/A from the prior year.
• EBT Margin came in at 158.57% for Q4 2023 at Perspective Therapeutics, up from 473.96% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 158.57% in Q4 2023 to a low of 740.4% in Q2 2023.
• The 5-year median for EBT Margin is 52.13% (2020), against an average of 129.93%.
• Across the five-year window, EBT Margin jumped 10180 bps in 2021 and tumbled 65745 bps in 2023, its largest moves.
• Perspective Therapeutics' EBT Margin stood at 40.66% in 2019, then gained by 10 bps to 36.8% in 2020, then tumbled by 55 bps to 56.96% in 2021, then plunged by 316 bps to 236.92% in 2022, then surged by 167 bps to 158.57% in 2023.
• The last three EBT Margin figures came in at 158.57% (Q4 2023), 473.96% (Q3 2023), and 740.4% (Q2 2023), per Business Quant data.